Select your country »
Featured Events

NAFLD Masterclass: Adelaide

Event Location

Date: Tue 22 May 18 - Tue 22 May 18
Location: 150 North Terrace ADELAIDE SA Australia 5000

Event Details

NAFLD Masterclass 

Non-alcoholic fatty liver disease (NAFLD) is emerging as the most common cause of liver disease worldwide, with its prevalence in Australia estimated at 30%.

NAFLD is the hepatic manifestation of metabolic syndrome, with a strong link to insulin resistance and obesity. As this is largely a lifestyle disease, there are multiple interventions that can be discussed within the pharmacy setting to assist in improving these customers’ well-being. This lecture teaches more about NAFLD and what options are available to prevent and manage this common illness. BioCeuticals is honoured to announce A/Prof. Martin Weltman as our guest speaker at this special event. A/Prof. Weltman is a leading gastroenterologist specialising in NAFLD, having researched and practiced clinically in the NAFLD space for over 20 years. His research published in the 1990s on the subject fundamentally changed the thinking of the medical fraternity on this disease and continues to be heavily cited.

6:00pm - 6:30pm             Registration & Buffet Dinner 

6:30pm - 7:30pm             Session 1

7:30pm – 7:45pm            Break 

7:45pm – 8:30pm            Session 2

NAFLD Masterclass             Tuesday 22 May 2018

6:00pm - 6:30pm             Registration & Buffet Dinner 

6:30pm - 7:30pm             Session 1

7:30pm – 7:45pm            Break 

7:45pm – 8:30pm            Session 2

Learning objectives: 

• Recognise the major features of NAFLD development and the key risk factors. 

• Identify patients at risk of NAFLD. 

• Review the research on lifestyle, dietary and CAM interventions to improve the prognosis of sufferers. 

• Review some of Dr Weltman’s case studies, looking at interventions and pathology. 

• Understand the CAM interventions that are effective and when to refer the patient on to their GP. 

Stamford Plaza Adelaide, Boulevard Room

Venue Information

Our Speakers

A/Prof Martin Weltman

Gastroenterologist, Hepatologist and specialist consultant for HealthEase. A/Prof. Martin Weltman is an experienced consultant gastroenterologist and hepatologist, with a strong interest in liver disorders, reflux oesophagitis, colon cancer and inflammatory bowel disease. He consults in private practice, is an Associate Professor of Medicine at the University of Sydney and also works as a Staff Specialist at Nepean Hospital, where he is also the Director of the Gastroenterology and Hepatology Department. A/Prof Weltman continues to manage a research team who currently are involved in a variety of studies in the fields of nonalcoholic fatty liver disease, hepatitis B and C, inflammatory bowel disease, infectious colitis and irritable bowel syndrome. He specialises in non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD), which occurs in approximately 30% of Australians.1 The author of more than 80 publications and a textbook, Gastroenterology and Hepatology: A Clinical Handbook, A/Prof. Weltman is also an editor and reviewer for specialist medical journals in the field of gastroenterology. He is a member of the Gastroenterology Society of Australia, Australian Liver Association, European Association for the Study of the Liver, and the American Association for the Study of the Liver.

Ref: #1600808434-3

Chat online with our team now

Patient support

If you are a patient or consumer, please contact your healthcare practitioner or pharmacist for advice, or find your nearest practitioner here.

Practitioner support

Log me In